Spire, Inc.
NYSE SR · St Louis, MO
Works in Musculoskeletal · Neurology · Respiratory
Spire, Inc. is a clinical trial sponsor based in St Louis, MO, listed as NYSE SR. It has 1 active clinical trial with 180 planned participants, in Musculoskeletal, Neurology and Respiratory. Since 2021 it has completed 3 trials and stopped 0 early.
Trial track record · since 2021
Financials · NYSE SR
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Spire, Inc
Spire, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 180 planned participants, in Musculoskeletal, Neurology, Respiratory. Since 2021 it has completed 3 trials and stopped 0 early.
Spire, Inc is based in St Louis, MO and is listed as NYSE SR. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Spire, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-20.
Approve Suite is not affiliated with Spire, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.